XT
YARW

XTX Topco’s Yarrow Bioscience YARW Stock Holding History

XTX Topco’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.2K Sell
1,574
-1,594
-50% -$51.7K ﹤0.01% 3713
2026
Q1 		$94.6K Buy
3,168
+1,587
+100% +$46.3K ﹤0.01% 3119
2025
Q4 		$45.9K Buy
+1,581
New +$31.7K ﹤0.01% 2858
2025
Q3 		– Sell
-1,138
Closed -$93.9K – 3357
2025
Q2 		$93.9K Buy
1,138
+477
+72% +$31K ﹤0.01% 1896
2025
Q1 		$52.2K Buy
661
+241
+57% +$29.7K ﹤0.01% 1996
2024
Q4 		$70.4K Buy
+420
New +$55K 0.01% 1836
2022
Q1 		– Sell
-19
Closed -$17K – 975
2021
Q4 		$17K Buy
+19
New +$20.4K 0.01% 633

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco's YARW Position: Q2 2026 in Review

XTX Topco reduced its Yarrow Bioscience (YARW) stake by 50% in Q2 2026, selling an estimated $51.7K and leaving 1,574 shares worth $51.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

XTX Topco first reported a position in YARW in Q4 2021 and has held it in 7 quarters since. The position peaked at $94.6K in Q1 2026. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • XTX Topco held 1,574 shares of Yarrow Bioscience worth $51.2K as of Q2 2026.
  • XTX Topco sold 1,594 Yarrow Bioscience shares in Q2 2026, an estimated $51.7K.
  • Yarrow Bioscience made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3713 holding.
  • XTX Topco first reported a position in Yarrow Bioscience in Q4 2021 and has held it in 7 quarters since.
  • XTX Topco's Yarrow Bioscience position peaked at $94.6K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.